Gaurav K. Guliani, MD, is a Staff Neurologist in the Department of Neurology at HealthPartners and serves as Medical Director of the Center for ALS and Neuromuscular Clinic. He is also an Assistant Professor of Neurology at the University of Minnesota Medical School. Dr. Guliani completed his MD at the University of Illinois College of Medicine and his neurology residency at the University of Minnesota, followed by advanced fellowship training in neuromuscular medicine and clinical neurophysiology at Washington University in St. Louis.

Dr. Guliani is a clinician‑scientist with expertise in neuromuscular disease, amyotrophic lateral sclerosis (ALS), myasthenia gravis, peripheral neuropathies, and motor neuron disorders, with extensive experience leading multidisciplinary care models and clinical trials. For more than a decade, his work has focused on improving diagnosis, clinical care, and therapeutic development for patients with complex neuromuscular and neurodegenerative conditions.

Conducting Institute research since: 2016

Current job title/position(s)

• Staff Physician, Department of Neurology, HealthPartners
• Medical Director, Center for ALS and Neuromuscular Clinic
• Director, AANEM‑Certified EMG Laboratory
• Assistant Professor of Neurology, University of Minnesota Medical School

Education and training

• BA, Integrative Neuroscience, Vanderbilt University (2003)
• MD, University of Illinois College of Medicine (2007)
• Neurology Residency, University of Minnesota (2011)
• Fellowship, Neuromuscular Medicine & Clinical Neurophysiology, Washington University in St. Louis (2012)

Affiliations / other offices held

• Site Leader, Northeast ALS Research Consortium (NEALS)
• Co‑Founder, Twin Cities ALS Research Consortium
• Allied clinician and researcher with the ALS Association (MN/ND/SD Chapter)
• Member, American Academy of Neurology (AAN)
• Member, American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
• Member, Myasthenia Gravis Foundation of America (MGFA)

Research interests

Advancing care and clinical trials for ALS and motor neuron disease. Dr. Guliani has served as Site Principal Investigator or Co‑Investigator on multiple multicenter ALS clinical trials, including Phase II and Phase III randomized controlled trials evaluating disease‑modifying and symptomatic therapies. He is an active leader within national and regional ALS research networks, including NEALS and the Twin Cities ALS Research Consortium, and has contributed to natural history and quality‑of‑life studies in ALS and related motor neuron disorders.

Translational research in neuromuscular and neuroimmunologic disorders. Dr. Guliani has been involved in investigator‑initiated and industry‑sponsored studies spanning myasthenia gravis, immune‑mediated neuropathies, multiple sclerosis, and neuromuscular junction disorders. His research portfolio includes advanced neuroimaging, biomarker development, and adherence‑focused intervention studies designed to bridge discovery science with real‑world clinical implementation.

Multidisciplinary models of neuromuscular care. As Medical Director of a high‑volume ALS and Neuromuscular Multidisciplinary Clinic, Dr. Guliani has led the implementation of coordinated care models integrating neurology, rehabilitation therapies, respiratory care, nutrition, palliative care, and research. His work emphasizes patient‑centered outcomes, access to clinical trials, and system‑level improvements in care delivery.

Current research activities and funding

• Site PI, The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis (Ad Scientiam, 2024-2026)
• Co-Investigator, Multicenter Longitudinal Imaging in ALS for Disease Biomarker Development (Minnesota Office of Higher Education, 2024-2028)
• Study Physician, Light vs. Moderate Intensity Exercise in Individuals with Myasthenia Gravis (Park Nicollet Foundation, 2024-2026)